Authors : Xu P; Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.; Research and Development Department, Shanghai Epiprobe Biotechnology Co., Ltd, Shanghai, China.

Subjects: SARS-CoV-2* ; COVID-19*; Humans

Source: Bioscience trends [Biosci Trends] 2023 Mar 11; Vol. 17 (1), pp. 81-84. Date of Electronic Publication: 2023 Jan 17.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Simulation of SARS-CoV-2 epidemic trends in Tokyo considering vaccinations, virus mutations, government policies and PCR tests.

Authors : Chu J; Department of Human and Engineered Environmental Studies, Graduate School of Frontier Science, The University of Tokyo, Kashiwa, Chiba, Japan.; Morikawa H

Subjects: SARS-CoV-2* ; COVID-19*; Humans

Source: Bioscience trends [Biosci Trends] 2023 Mar 11; Vol. 17 (1), pp. 38-53. Date of Electronic Publication: 2023 Feb 11.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Verification of the efficiency of saline gargle sampling for detection of the Omicron variant of SARS-CoV-2, a pilot study.

Authors : Qiao K; Department of Thoracic Surgery, National Clinical Research Center for Infectious Diseases, Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.; Tao X

Subjects: SARS-CoV-2* ; COVID-19*/COVID-19*/COVID-19*/diagnosis; Humans SARS-CoV-2 variants

Source: Bioscience trends [Biosci Trends] 2022 Dec 26; Vol. 16 (6), pp. 451-454. Date of Electronic Publication: 2022 Dec 09.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Immunity debt: Hospitals need to be prepared in advance for multiple respiratory diseases that tend to co-occur.

Authors : Li T; Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the Third People's Hospital of Shenzhen, Shenzhen, Guangdong, China.; Centre for Environment and Population Health, School of Medicine and Dentistry, Griffith University, Brisbane, Australia.

Subjects: COVID-19* ; Respiratory Tract Infections*/Respiratory Tract Infections*/Respiratory Tract Infections*/epidemiology ; Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology

Source: Bioscience trends [Biosci Trends] 2024 Jan 30; Vol. 17 (6), pp. 499-502. Date of Electronic Publication: 2023 Dec 08.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule.

Authors : Zhang J; Department of Internal Medicine, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.; Liu L

Subjects: COVID-19* ; SARS-CoV-2*; China SARS-CoV-2 variants

Source: Bioscience trends [Biosci Trends] 2022 Jul 20; Vol. 16 (3), pp. 238-241. Date of Electronic Publication: 2022 Jun 22.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19?

Authors : Li J; Department of Pharmacology, School of Pharmacy, Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.; Yan Y

Subjects: Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/antagonists & inhibitors ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

Source: Bioscience trends [Biosci Trends] 2022; Vol. 16 (6), pp. 459-461.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

More effective vaccines and oral antivirals: Keys for the battle against Omicron.

Authors : Lu H; National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; SARS-CoV-2* ; COVID-19 Drug Treatment*SARS-CoV-2 variants

Source: Bioscience trends [Biosci Trends] 2022 Mar 11; Vol. 16 (1), pp. 1-3. Date of Electronic Publication: 2022 Feb 17.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19.

Authors : Su J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.; State Key Laboratory of Medical Genomics, Ruijin Hospital Affiliated with the Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai, China.

Subjects: COVID-19 Drug Treatment*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*therapeutic use

Source: Bioscience trends [Biosci Trends] 2021 Sep 22; Vol. 15 (4), pp. 205-210. Date of Electronic Publication: 2021 Jun 16.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Emerging infectious diseases never end: The fight continues.

Authors : Yang Y; National Clinical Research Center for Infectious Diseases, State Key Discipline of Infectious Diseases, Shenzhen Third People's Hospital, Second Hospital Affiliated with the Southern University of Science and Technology, Shenzhen, China.; Guo L

Subjects: COVID-19* ; Communicable Diseases, Emerging*/Communicable Diseases, Emerging*/Communicable Diseases, Emerging*/epidemiology; Animals

Source: Bioscience trends [Biosci Trends] 2023 Jul 11; Vol. 17 (3), pp. 245-248. Date of Electronic Publication: 2023 Jun 16.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list

Academic Journal

Rapid evolution of the COVID-19 pandemic calls for a unified public health response.

Authors : He N; Department of Epidemiology, School of Public Health and Ministry of Education Key Laboratory of Public Health Safety, Fudan University; Shanghai Institute of Infectious Diseases and Biosafety

Subjects: Pandemics*; COVID-19/COVID-19/COVID-19/*epidemiology ; SARS-CoV-2/SARS-CoV-2/SARS-CoV-2/*genetics

Source: Bioscience trends [Biosci Trends] 2021 Sep 22; Vol. 15 (4), pp. 196-200. Date of Electronic Publication: 2021 Jul 01.Publisher: International Research and Cooperation Association for Bio & Socio-Sciences Advancement Country of Publication: Japan NLM ID: 101502754 Publication

Record details

Read Online Read More Add to Saved list